Exact Sciences Launches Cologuard Plus

New Test Will ‘Significantly Reduce False Positives’

The Cologuard Plus test has a sensitivity of 95% and a specificity of 94% for the detection of colorectal cancer; “unmatched accuracy,” according to Exact Sciences.

lab testing
(Shutterstock)

Exact Sciences is launching what the company calls the “most accurate noninvasive colorectal cancer screening test reported in studies to date.”

The Cologuard Plus test, which was approved by the US Food and Drug Administration (FDA) in

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Clinical Trials

More from Geography